United States Transdermal Drug Delivery Market Report 2016

November 2016 | 103 pages | ID: U8BFE6872ECEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Transdermal Drug Delivery

Revenue, means the sales value of Transdermal Drug Delivery

This report studies sales (consumption) of Transdermal Drug Delivery in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Actavis
• Actelion
• GlaxoSmithKline
• Bayer
• Mylan Pharmaceuticals
• Novartis

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Transdermal Drug Delivery in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Transdermal Drug Delivery Market Report 2016

1 TRANSDERMAL DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of Transdermal Drug Delivery
1.2 Classification of Transdermal Drug Delivery
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Transdermal Drug Delivery
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Transdermal Drug Delivery (2011-2021)
  1.4.1 United States Transdermal Drug Delivery Sales and Growth Rate (2011-2021)
  1.4.2 United States Transdermal Drug Delivery Revenue and Growth Rate (2011-2021)

2 UNITED STATES TRANSDERMAL DRUG DELIVERY COMPETITION BY MANUFACTURERS

2.1 United States Transdermal Drug Delivery Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Transdermal Drug Delivery Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Transdermal Drug Delivery Average Price by Manufactures (2015 and 2016)
2.4 Transdermal Drug Delivery Market Competitive Situation and Trends
  2.4.1 Transdermal Drug Delivery Market Concentration Rate
  2.4.2 Transdermal Drug Delivery Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES TRANSDERMAL DRUG DELIVERY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Transdermal Drug Delivery Sales and Market Share by Type (2011-2016)
3.2 United States Transdermal Drug Delivery Revenue and Market Share by Type (2011-2016)
3.3 United States Transdermal Drug Delivery Price by Type (2011-2016)
3.4 United States Transdermal Drug Delivery Sales Growth Rate by Type (2011-2016)

4 UNITED STATES TRANSDERMAL DRUG DELIVERY SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Transdermal Drug Delivery Sales and Market Share by Application (2011-2016)
4.2 United States Transdermal Drug Delivery Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES TRANSDERMAL DRUG DELIVERY MANUFACTURERS PROFILES/ANALYSIS

5.1 Actavis
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Transdermal Drug Delivery Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Actavis Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Actelion
  5.2.2 Transdermal Drug Delivery Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Actelion Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline
  5.3.2 Transdermal Drug Delivery Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Bayer
  5.4.2 Transdermal Drug Delivery Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Bayer Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Mylan Pharmaceuticals
  5.5.2 Transdermal Drug Delivery Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Mylan Pharmaceuticals Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Novartis
  5.6.2 Transdermal Drug Delivery Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Novartis Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview

6 TRANSDERMAL DRUG DELIVERY MANUFACTURING COST ANALYSIS

6.1 Transdermal Drug Delivery Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Transdermal Drug Delivery

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Transdermal Drug Delivery Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Transdermal Drug Delivery Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES TRANSDERMAL DRUG DELIVERY MARKET FORECAST (2016-2021)

10.1 United States Transdermal Drug Delivery Sales, Revenue Forecast (2016-2021)
10.2 United States Transdermal Drug Delivery Sales Forecast by Type (2016-2021)
10.3 United States Transdermal Drug Delivery Sales Forecast by Application (2016-2021)
10.4 Transdermal Drug Delivery Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Transdermal Drug Delivery
Table Classification of Transdermal Drug Delivery
Figure United States Sales Market Share of Transdermal Drug Delivery by Type in 2015
Table Application of Transdermal Drug Delivery
Figure United States Sales Market Share of Transdermal Drug Delivery by Application in 2015
Figure United States Transdermal Drug Delivery Sales and Growth Rate (2011-2021)
Figure United States Transdermal Drug Delivery Revenue and Growth Rate (2011-2021)
Table United States Transdermal Drug Delivery Sales of Key Manufacturers (2015 and 2016)
Table United States Transdermal Drug Delivery Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Transdermal Drug Delivery Sales Share by Manufacturers
Figure 2016 Transdermal Drug Delivery Sales Share by Manufacturers
Table United States Transdermal Drug Delivery Revenue by Manufacturers (2015 and 2016)
Table United States Transdermal Drug Delivery Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Transdermal Drug Delivery Revenue Share by Manufacturers
Table 2016 United States Transdermal Drug Delivery Revenue Share by Manufacturers
Table United States Market Transdermal Drug Delivery Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Transdermal Drug Delivery Average Price of Key Manufacturers in 2015
Figure Transdermal Drug Delivery Market Share of Top 3 Manufacturers
Figure Transdermal Drug Delivery Market Share of Top 5 Manufacturers
Table United States Transdermal Drug Delivery Sales by Type (2011-2016)
Table United States Transdermal Drug Delivery Sales Share by Type (2011-2016)
Figure United States Transdermal Drug Delivery Sales Market Share by Type in 2015
Table United States Transdermal Drug Delivery Revenue and Market Share by Type (2011-2016)
Table United States Transdermal Drug Delivery Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Transdermal Drug Delivery by Type (2011-2016)
Table United States Transdermal Drug Delivery Price by Type (2011-2016)
Figure United States Transdermal Drug Delivery Sales Growth Rate by Type (2011-2016)
Table United States Transdermal Drug Delivery Sales by Application (2011-2016)
Table United States Transdermal Drug Delivery Sales Market Share by Application (2011-2016)
Figure United States Transdermal Drug Delivery Sales Market Share by Application in 2015
Table United States Transdermal Drug Delivery Sales Growth Rate by Application (2011-2016)
Figure United States Transdermal Drug Delivery Sales Growth Rate by Application (2011-2016)
Table Actavis Basic Information List
Table Actavis Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actavis Transdermal Drug Delivery Sales Market Share (2011-2016)
Table Actelion Basic Information List
Table Actelion Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actelion Transdermal Drug Delivery Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Transdermal Drug Delivery Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Transdermal Drug Delivery Sales Market Share (2011-2016)
Table Mylan Pharmaceuticals Basic Information List
Table Mylan Pharmaceuticals Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Pharmaceuticals Transdermal Drug Delivery Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Transdermal Drug Delivery Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transdermal Drug Delivery
Figure Manufacturing Process Analysis of Transdermal Drug Delivery
Figure Transdermal Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Transdermal Drug Delivery Major Manufacturers in 2015
Table Major Buyers of Transdermal Drug Delivery
Table Distributors/Traders List
Figure United States Transdermal Drug Delivery Production and Growth Rate Forecast (2016-2021)
Figure United States Transdermal Drug Delivery Revenue and Growth Rate Forecast (2016-2021)
Table United States Transdermal Drug Delivery Production Forecast by Type (2016-2021)
Table United States Transdermal Drug Delivery Consumption Forecast by Application (2016-2021)